Citrine Global Corp.
- Jurisdiction
Israel - LEI
549300TQFI134MZLRI98 - ISIN
US17737V1052 (CTGL )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Citrine Global Corp. operates as a plant-based wellness and pharma solutions company. Read full profile
Stock price
Fundamentals
- Net revenue
-€265.98M - Gross margin
100.0% - EBIT
€1.38M - EBIT margin
-0.5% - Net income
-€1.69M - Net margin
0.6%
Statement period: - (published )
Dividends
No dividend payouts